Global Organs-on-Chips Market to Reach $497.3 Billion by 2030
The global market for Organs-on-Chips estimated at US$44.3 Billion in the year 2022, is projected to reach a revised size of US$497.3 Billion by 2030, growing at a CAGR of 35.3% over the analysis period 2022-2030. Liver, one of the segments analyzed in the report, is projected to record 36.7% CAGR and reach US$186.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kidney segment is readjusted to a revised 37.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $13.4 Billion, While China is Forecast to Grow at 33.5% CAGR
The Organs-on-Chips market in the U.S. is estimated at US$13.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 32% and 30.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 24.5% CAGR.Select Competitors (Total 12 Featured) -
- Ascendance Biotechnology, Inc.
- AxoSim, Inc.
- CN Bio Innovations Ltd.
- Emulate, Inc.
- Hurel Corporation
- InSphero AG
- Kirkstall Ltd.
- Mimetas
- Nortis, Inc.
- SynVivo
- TissUse GmbH
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Organs-on-Chips - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 4: World 8-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 6: World 8-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World 8-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 10: World 8-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 12: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 16: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 17: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- Table 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- Table 20: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 21: World 8-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 23: USA 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 25: USA 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- CANADA
- Table 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: Canada 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: Canada 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- JAPAN
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: Japan 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Japan 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- CHINA
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: China 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: China 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- EUROPE
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 39: Europe 8-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- Table 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 41: Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- FRANCE
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: France 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: France 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- GERMANY
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: Germany 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Germany 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- ITALY
- Table 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: Italy 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: Italy 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- UNITED KINGDOM
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: UK 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: UK 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- REST OF EUROPE
- Table 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: Rest of Europe 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Rest of Europe 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- ASIA-PACIFIC
- Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Asia-Pacific 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Asia-Pacific 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
- REST OF WORLD
- Table 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Rest of World 8-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2023 & 2030
- Table 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Rest of World 8-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ascendance Biotechnology, Inc.
- AxoSim, Inc.
- CN Bio Innovations Ltd.
- Emulate, Inc.
- Hurel Corporation
- InSphero AG
- Kirkstall Ltd.
- Mimetas
- Nortis, Inc.
- SynVivo
- TissUse GmbH
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 44.3 Billion |
Forecasted Market Value ( USD | $ 497.3 Billion |
Compound Annual Growth Rate | 35.3% |
Regions Covered | Global |